Follow
Dr Brett W Stringer
Dr Brett W Stringer
Brain Cancer Research Fellow, Flinders University
Verified email at flinders.edu.au
Title
Cited by
Cited by
Year
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake
WA Flavahan, Q Wu, M Hitomi, N Rahim, Y Kim, AE Sloan, RJ Weil, ...
Nature neuroscience 16 (10), 1373-1382, 2013
4852013
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme
BW Day, BW Stringer, F Al-Ejeh, MJ Ting, J Wilson, KS Ensbey, ...
Cancer cell 23 (2), 238-248, 2013
2532013
A metabolic shift favoring sphingosine 1-phosphate at the expense of ceramide controls glioblastoma angiogenesis
HJ Abuhusain, A Matin, Q Qiao, H Shen, N Kain, BW Day, BW Stringer, ...
Journal of Biological Chemistry 288 (52), 37355-37364, 2013
1522013
A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
BW Stringer, BW Day, RCJ D’Souza, PR Jamieson, KS Ensbey, ZC Bruce, ...
Scientific reports 9 (1), 4902, 2019
1482019
Differential response of patient-derived primary glioblastoma cells to environmental stiffness
TJ Grundy, E De Leon, KR Griffin, BW Stringer, BW Day, B Fabry, ...
Scientific reports 6 (1), 23353, 2016
1022016
Extracellular vesicles released by glioblastoma cells stimulate normal astrocytes to acquire a tumor-supportive phenotype via p53 and MYC signaling pathways
S Hallal, DM Mallawaaratchy, H Wei, S Ebrahimkhani, BW Stringer, ...
Molecular neurobiology 56, 4566-4581, 2019
992019
The glycosylphosphatidylinositol-anchored serine protease PRSS21 (testisin) imparts murine epididymal sperm cell maturation and fertilizing ability
S Netzel-Arnett, TH Bugge, RA Hess, K Carnes, BW Stringer, AL Scarman, ...
Biology of reproduction 81 (5), 921-932, 2009
972009
Eph receptors as therapeutic targets in glioblastoma
BW Day, BW Stringer, AW Boyd
British journal of cancer 111 (7), 1255-1261, 2014
922014
Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif
GA Darnell, TM Antalis, RW Johnstone, BW Stringer, SM Ogbourne, ...
Molecular and cellular biology 23 (18), 6520-6532, 2003
902003
Increased sensitivity to ionizing radiation by targeting the homologous recombination pathway in glioma initiating cells
YC Lim, TL Roberts, BW Day, BW Stringer, S Kozlov, S Fazry, ZC Bruce, ...
Molecular oncology 8 (8), 1603-1615, 2014
852014
NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development
M Piper, G Barry, TJ Harvey, R McLeay, AG Smith, L Harris, S Mason, ...
Journal of Neuroscience 34 (8), 2921-2930, 2014
812014
Neurosphere and adherent culture conditions are equivalent for malignant glioma stem cell lines
M Rahman, K Reyner, L Deleyrolle, S Millette, H Azari, BW Day, ...
Anatomy & cell biology 48 (1), 25, 2015
732015
Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma
SA Greenall, YC Lim, CB Mitchell, KS Ensbey, BW Stringer, AL Wilding, ...
Oncogenesis 6 (5), e336-e336, 2017
702017
Glioma surgical aspirate: a viable source of tumor tissue for experimental research
BW Day, BW Stringer, J Wilson, RL Jeffree, PR Jamieson, KS Ensbey, ...
Cancers 5 (2), 357-371, 2013
602013
The effect of valproic acid in combination with irradiation and temozolomide on primary human glioblastoma cells
AN Hosein, YC Lim, B Day, B Stringer, S Rose, R Head, L Cosgrove, ...
Journal of neuro-oncology 122, 263-271, 2015
552015
A unique 19 F MRI agent for the tracking of non phagocytic cells in vivo
SS Moonshi, C Zhang, H Peng, S Puttick, S Rose, NM Fisk, K Bhakoo, ...
Nanoscale 10 (17), 8226-8239, 2018
492018
Intratumoural heterogeneity underlies distinct therapy responses and treatment resistance in glioblastoma
S Akgül, AM Patch, RCJ D’souza, P Mukhopadhyay, K Nones, S Kempe, ...
Cancers 11 (2), 190, 2019
462019
Structural optimization and pharmacological evaluation of inhibitors targeting dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) and CDC-like kinases (CLK) in …
Q Zhou, AF Phoa, RH Abbassi, M Hoque, TA Reekie, JS Font, RM Ryan, ...
Journal of Medicinal Chemistry 60 (5), 2052-2070, 2017
462017
Using the apparent diffusion coefficient to identifying MGMT promoter methylation status early in glioblastoma: importance of analytical method
D Rundle‐Thiele, B Day, B Stringer, M Fay, J Martin, RL Jeffree, ...
Journal of medical radiation sciences 62 (2), 92-98, 2015
402015
ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1
BW Day, BW Stringer, MD Spanevello, S Charmsaz, PR Jamieson, ...
Neuro-oncology 13 (11), 1202-1212, 2011
392011
The system can't perform the operation now. Try again later.
Articles 1–20